The 34 references in paper V. Nikolenko N., S. Kozlov V., E. Kochurova V., В. Николенко Н., С. Козлов В., Е. Кочурова В. (2015) “ДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ ИССЛЕДОВАНИЯ РОТОВОЙ ЖИДКОСТИ В ОНКОЛОГИИ // DIAGNOSTIC ABILITIES OF THE ORAL FLUID IN ONCOLOGY” / spz:neicon:ogsh:y:2013:i:1:p:39-42

1
Petersen P.E. Strengthening the prevention of oral cancer: the WHO perspective. Community Dent Oral Epidemiol
(check this in PDF content)
2
05;33(6):397–9. 2. Чиссов В.И., Старинский В.В., Петров а Г.В. Злокачественные новообразования в России в 2010 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздравсоцразвития России, 2012.
(check this in PDF content)
3
American Cancer Society: Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society, 2012.
(check this in PDF content)
4
Ferlay J., Bray F., Pisani P., Parkin D.M. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, Version 1.0. Lyon: IARC Press, 2001.
(check this in PDF content)
5
Peacock Z.S., Pogrel M.A., Schmidt B.L. Exploring the reasons for delay in treatment of oral cancer. J Am Dent Assoc 2008;139(10):1346–52.
(check this in PDF content)
6
Schantz S.P. Biologic markers, cellular differentiation, and metastatic head and neck cancer. Eur Arch Otorhinolaryngol 1993;250(8):424–8.
(check this in PDF content)
7
Schantz S.P. Carcinogenesis, markers, staging, and prognosis of head and neck cancer. Curr Opin Oncol 1993;5(3):483–90.
(check this in PDF content)
8
Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2(3):210–9.
(check this in PDF content)
9
Ellison M.D., Campbell B.H. Screening for cancers of the head and neck: addressing the problem. Surg Oncol Clin N Am 1999;8(4):725–34.
(check this in PDF content)
10
Azuma M., Kasai Y., Tamatani T., Sato M. Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomas. Cancer Lett 1992;65(1):61–71.
(check this in PDF content)
11
Streckfus C., Bigler L., Tucci M., Thigpen J.T. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest 2000;18(2):101–9.
(check this in PDF content)
12
Corstjens PLAMMD. Point-of-care Diagnostics for infectious diseases. In: Wong D.T., editor. Saliva Diagnostics. Ames: Wiley-Blackwell, 2008. Pp. 243–254.
(check this in PDF content)
13
Farnaud S.J., Kosti O., Getting S.J., Renshaw D. Saliva: physiology and diagnostic potential in health and disease. Scientific World Journal 2010;10:434–56.
(check this in PDF content)
14
Streckfus C., Bigler L. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv Dent Res 2005;18(1):17–24.
(check this in PDF content)
15
Chen D.X., Schwartz P.E., Li F.Q. Saliva and serum CA 125 assays for detecting malignant ovarian tumors. Obstet Gynecol 1990;75(4):701–4.
(check this in PDF content)
16
Blackburn A.C., Hill L.Z., Roberts A.L. et al. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol 2007;170(6):2030–41.
(check this in PDF content)
17
Braidotti P., Nuciforo P.G., Mollenhauer J. et al. DMBT1 expression is down-regulated in breast cancer. BMC Cancer 2004;4:46.
(check this in PDF content)
18
Zhаng L., Hуnsоn B.S., Cаmаrgо Р.М., Wong D.T. The clinical value of salivary biomarkers for periodontal disease. Periodontol 2000. 2009;51:25–37.
(check this in PDF content)
19
Malamud D. Saliva as a diagnostic fluid. Dent Clin North Am 2011;55(1):159–78.
(check this in PDF content)
20
Schmidt B., Engel E., Carstensen T. et al. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? Lung Cancer 2005;48(1):145–7.
(check this in PDF content)
21
Kopreski M.S., Benko F.A., Gocke C.D. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci 2001;945:172–8.
(check this in PDF content)
22
Hasselmann D.O., Rappl G., Rössler M. et al. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. Oncol Rep 2001;8(1):115–8.
(check this in PDF content)
23
Bryzgunova O.E., Skvortsova T.E., Kolesnikova E.V. et al. Isolation and comparative study of cell-free nucleic acids from human urine. Ann N Y Acad Sci 2006;1075:334–40.
(check this in PDF content)
24
Yoneda K., Iida H., Endo H. et al. Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Int J Oncol 2009;35(1):33–40.
(check this in PDF content)
25
St. John M., Li Y., Zhou X. et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130(8):929–35.
(check this in PDF content)
26
Li Y., St. John M.A., Zhou X. et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10(24):8442–50.
(check this in PDF content)
27
Bont J.M., van Doorn J., Reddingius R.E. et al. Various components of the insulin-like growth factor system in tumour tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients. Int J Cancer 2008;123(3):594–600.
(check this in PDF content)
28
Johnson P.J., Lo Y.M. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 2002;48(8):1186–93.
(check this in PDF content)
29
Neves A.F., Araújo T.G., Biase W.K. et al. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. Clin Biochem 2008;41(14–15): 1191–8.
(check this in PDF content)
30
Honma H., Kanda T., Ito H. et al. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma. Surgery 2006;139(5):678–85.
(check this in PDF content)
31
El-Abd E., El-Tahan R., Fahmy L. et al. Serum metastasin mRNA is an important survival predictor in breast cancer. Br J Biomed Sci 2008;65(2):90–4.
(check this in PDF content)
32
Voorzanger-Rousselot N., Goehrig D., Journe F. et al. Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 2007;97(7):964–70.
(check this in PDF content)
33
Siddiqua A., Chendil D., Rowland R. et al. Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer. Urology 2002;60(2):270–5.
(check this in PDF content)
34
Ogawa O., Iinuma M., Sato K. et al. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special
(check this in PDF content)